Endeavor

Why Miles for Moffitt? — A Family’s Perspective

Now a two-time survivor, Vicki calls on her "soldiers" each year to contribute to her Miles for Moffitt team.

Why I Run

In her own words, Dr. Dana Rollison explains why Miles for Moffitt is much more than another fundraiser.

More Blood Pressure Drugs Recalled Due to Potential Cancer Risk

This is the third recall for this type of medication in 2018.

Nearly 40 Percent of CAR T Patients Remain in Remission

Many ZUMA-1 participants remain in remission and more than half of those treated remain alive.

10 Things to Know For Race Day

We’re here to help you gear up for Miles for Moffitt in downtown Tampa

Five Fitness Tips for Cancer Patients

Prepare now to participate in Miles for Moffitt

New Study Shows CAR T-cell Therapy for Lymphoma Lives up to its Press

Seventeen cancer centers compare real world outcomes of diffuse large B cell lymphoma patients treated with Yescarta® to ZUMA-1 clinical trial data

Cancer Could Replace Heart Disease as Leading Killer of Americans by 2020

Moffitt expert weighs in on a new study suggesting cancer may soon become the No. 1 killer in the U.S.

Lung Cancer Has a Sweet Tooth

Researchers have found that early-stage NSCLC tumors or pre-cancerous lesions can give themselves away.